Cesca Therapeutics (KOOL) Hits New 1-Year High and Low at $0.52

Cesca Therapeutics (NASDAQ:KOOL) hit a new 52-week high and low during trading on Thursday . The company traded as low as $0.52 and last traded at $0.52, with a volume of 20194 shares trading hands. The stock had previously closed at $0.52.

Separately, ValuEngine raised shares of Cesca Therapeutics from a “sell” rating to a “hold” rating in a report on Wednesday, May 2nd.

The company has a current ratio of 1.61, a quick ratio of 1.23 and a debt-to-equity ratio of 0.23.

Cesca Therapeutics (NASDAQ:KOOL) last announced its earnings results on Thursday, March 22nd. The biotechnology company reported $0.01 EPS for the quarter. Cesca Therapeutics had a negative net margin of 56.21% and a negative return on equity of 20.31%. The business had revenue of $2.94 million during the quarter.

About Cesca Therapeutics

Cesca Therapeutics Inc develops, commercializes, and markets a range of automated technologies and products for cell-based therapeutics in the United States, China, rest of Asia, Europe, and internationally. The company develops automated blood and bone marrow processing systems that enable the separation, processing, and preservation of cell and tissue therapy products.

Receive News & Ratings for Cesca Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cesca Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit